Hutchinson Cancer Center Wins $13M for Colorectal Cancer GWAS Consortium | GenomeWeb

NEW YORK (GenomeWeb News) – Fred Hutchinson Cancer Research Center scientists will use a $13 million award from the National Cancer Institute to fund a consortium that will use genome sequencing and genome-wide association study data to identify rare genetic variants that may be involved in colorectal cancer.

Ulrike Peters, a member of the Hutchinson Center's Public Health Sciences Division, will lead the effort, which also will involve partners through the Genetics and Epidemiology of Colorectal Cancer Consortium (GECCO), for which Peters is principal investigator.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.